| （単位：千ドル） | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 | 2Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | - | - | 29,465 | 35,776 | - | - | - | - | - | - | - | - | - | - | - | - |
| 営業費用 | - | - | 44,675 | 49,622 | - | - | - | - | - | - | - | - | - | - | - | - |
| 営業利益 | - | -1,539 | -44,675 | -49,622 | - | - | - | - | - | - | - | - | - | - | - | - |
| 純利益 | -63 | -1,463 | -75,079 | 80,988 | 15,351 | -90,353 | -94,837 | -117,653 | -104,631 | -116,507 | -110,602 | -120,628 | -122,953 | -119,699 | -114,423 | -114,698 |
| 一株あたり利益 | - | - | - | 0.2 | - | - | - | - | - | - | - | - | - | - | - | - |
| 希薄化後一株あたり利益 | - | - | - | -0.12 | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |